Optiver Holding’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50K Buy
5,582
+5,073
+997% +$45.5K ﹤0.01% 349
2025
Q1
$3.82K Buy
509
+460
+939% +$3.45K ﹤0.01% 878
2024
Q4
$368 Buy
+49
New +$368 ﹤0.01% 687
2024
Q3
Sell
-936
Closed -$5.78K 628
2024
Q2
$5.78K Buy
+936
New +$5.78K ﹤0.01% 435